Activist Shareholder Fails In Bid To Control Actelion
This article was originally published in The Pink Sheet Daily
Executive Summary
Actelion shareholders reject Elliott Advisors' board nominees in show of support for management at May 5 AGM. But this is unlikely to be the end of the story.
You may also be interested in...
Actelion Management Re-Shuffle Reflects Continued Activist Pressure
Changes include new COO role, new business development chief and spinning off non-core assets.
Radiopharmaceuticals: A New Frontier In Precision Cancer Therapy
Growing interest in radioligand-based cancer therapies reflects the class’s unique advantages – including the ability to “see what you treat.”